FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role
Clinical trial NCT04333524 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04333524
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-01
- Primary completion
- 2026-10-15
- Enrollment
- 496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.